Journals / Gazi University Journal of Science / 2017 / Cilt: 30 - Sayı: 1

Synthesis, Crystal Structure, Spectroscopic and Density Functional Modelling Studies of The 2-Isopropylbenzimidazolium Tetrachloroplatinate(II) Monohydrate

Pages
139–159
Publication Date
2017-03-14
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There exists a good correlation between experimental and theoretical data for the complex.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Synthesis, crystallographic characterization, spectroscopic and density functional modelling studies of the 2-isopropylbenzimidazolium tetrachloroplatinate monohydrate (C10H13N2)2.[PtCl4].H2O have been reported.
📊
Key Findings & Data:The compound is comprised of 2-isopropylbenzimidazole (Hipb)+: (C10H13N2)+ and [PtCl4]2- ions, respectively, linked by intermolecular hydrogen bonds N…Cl [3.249(4) from 3.660(7) Å], C…Cl [range from 3.553(7) to 3.895(7) Å] and O atom of anon-coordinating water molecule in the crystal structure N…O [2.728(8) Å], O…Cl [range from 3.234(6) to 3.451(7) Å], C…O [range from 3.350(7) to 3.545(1) Å] for the investigated compound.
💡
Conclusion & Impact:There exists a good correlation between experimental and theoretical data for the complex.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Crystal structure · platinate salts · benzimidazole

Abstract

Synthesis, crystallographic characterization, spectroscopic and density functional modelling studies of the 2-isopropylbenzimidazolium tetrachloroplatinate monohydrate (C10H13N2)2.[PtCl4].H2O have been reported. The molecular structure of the compound was determined by single-crystal X-ray diffraction analysis. In the compound, the Pt atoms reside at a center of inversion. The compound is comprised of 2-isopropylbenzimidazole (Hipb)+: (C10H13N2)+ and [PtCl4]2- ions, respectively, linked by intermolecular hydrogen bonds N…Cl [3.249(4) from 3.660(7) Å], C…Cl [range from 3.553(7) to 3.895(7) Å] and O atom of anon-coordinating water molecule in the crystal structure N…O [2.728(8) Å], O…Cl [range from 3.234(6) to 3.451(7) Å], C…O [range from 3.350(7) to 3.545(1) Å] for the investigated compound. The molecular structure obtained from X-ray single-crystal analysis of the investigated compound in the ground state has been compared using Hartree-Fock (HF) and density functional theory (DFT) with the functionals B3LYP and PBE1PBE using the LANL2DZ basis set. The experimental (spectroscopic) and calculated vibrational frequencies (using DFT) of the title compound have been compared. There exists a good correlation between experimental and theoretical data for the complex.

🔖

Cite This Article

GOZELLE, M., ZEYREK, C. T., ÜNVER, H., DİLEK, N., GÜMÜŞ, F. (2017). Synthesis, Crystal Structure, Spectroscopic and Density Functional Modelling Studies of The 2-Isopropylbenzimidazolium Tetrachloroplatinate(II) Monohydrate. Gazi University Journal of Science, Cilt: 30 - Sayı: 1, 139–159. https://ajindex.com/articles/254799

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Denny, W.A., Rewcastle, G.W. and Baguley, B.C., “Potential antitumor agents; structure-activity-relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of minimal DNA-intercalating agents which may not act via topoisomerase-II”, J. Med. Chem., 33(2): 814-819, (1990).
  2. Gravatt, G.L., Baguley, B.C., Wilson, W.R. and Denny, W.A., “Na-directed alkylating-agents; synthesis and antitumor-activity of DNA minor groove-targeted aniline mustard analogs of pibenzimol (Hoechst-33258)”, J. Med. Chem., 37(25): 4338-4345, (1994).
  3. Kim, J.S., Gatto, B., Yu, C., Liu, A., Liu, L.F. and LaVoie, E.J., “Substituted 2,5'-bi-1H-benzimidazoles: Topoisomerase I inhibition and cytotoxicity”, J. Med. Chem., 39(4):992-998, (1996)
  4. Horton, D.A., Bourne, G.T. and Smythe, M.L., “The combinatorial synthesis of bicyclic privileged structures or privileged substructures”, Chem. Rev., 103(3): 893-930, (2003).
  5. Bradshaw, T.D., Wrigley, S., Shi, D.F., Schultz, R.J., Paull, K.D. and Stevens, M.F.G., “2-(4-aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity”, Brit. J. Cancer., 77(5): 745-752, (1998).
  6. Payne, J.E., Bonnefous, C., Symons, K.T., Nquyen, P.M., Sablad, M., Rozenkrants, N., Zhang, Y., Wang, L., Wang, L., Yazdani, N., Shiau, A.K., Noble, S.A., Rix, P., Rao, T.S., Hassiq, C.A. and Smith, N.D., “Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-(2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) Part 2: Identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models”, J. Med. Chem., 53(21): 7739-7755, (2010).
  7. Roth, T., Morningstar, M.L., Boyer, P.L., Hughes, S.H., Buckheit, R.W. and Michejda, C.J., “Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-aryl-substituted benzimidazoles”, J. Med. Chem., 40(26): 4199-4207, (1997).
  8. Galal, S.A., Hegab, K.H., Kassab, A.S., Rodriguez, M. L., Kerwin, S.M., El-Khamry, A.A. and El Diwani, H.I., “New transition metal ion complexes with benzimidazole-5-carboxylic acid hydrazides with antitumor activity”, Eur. J. Med. Chem., 44(4): 1500-1508, (2009).
  9. Wang, X.L., Hou, L.L., Zhang, J.W., Gong, C.H. and Liu, G.C., “Bis(benzimidazole)-based ligands-directed the various dimensionality of metal-organic complexes based on carboxylates co-ligands: Syntheses, structures and p